These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23462097)

  • 1. Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor.
    Zanuy D; Kotla R; Nussinov R; Teesalu T; Sugahara KN; Alemán C; Haspel N
    J Struct Biol; 2013 May; 182(2):78-86. PubMed ID: 23462097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.
    Haspel N; Zanuy D; Nussinov R; Teesalu T; Ruoslahti E; Aleman C
    Biochemistry; 2011 Mar; 50(10):1755-62. PubMed ID: 21247217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.
    Teesalu T; Sugahara KN; Kotamraju VR; Ruoslahti E
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16157-62. PubMed ID: 19805273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
    Baek DS; Kim JH; Kim YJ; Kim YS
    Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of a C-end rule peptide adsorbed onto gold nanoparticles.
    Triguero J; Flores-Ortega A; Zanuy D; Alemán C
    J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29231280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
    J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
    Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
    Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tLyp-1: A peptide suitable to target NRP-1 receptor.
    Larue L; Kenzhebayeva B; Al-Thiabat MG; Jouan-Hureaux V; Mohd-Gazzali A; Wahab HA; Boura C; Yeligbayeva G; Nakan U; Frochot C; Acherar S
    Bioorg Chem; 2023 Jan; 130():106200. PubMed ID: 36332316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.
    Paoli EE; Ingham ES; Zhang H; Mahakian LM; Fite BZ; Gagnon MK; Tam S; Kheirolomoom A; Cardiff RD; Ferrara KW
    J Control Release; 2014 Mar; 178():108-17. PubMed ID: 24434424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
    FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
    Sabki A; Khelifi L; Kameli A; Baali S
    Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.
    Tymecka D; Lipiński PFJ; Fedorczyk B; Puszko A; Wileńska B; Perret GY; Misicka A
    Peptides; 2017 Aug; 94():25-32. PubMed ID: 28627371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT and near-infrared fluorescence imaging of breast cancer with a neuropilin-1-targeting peptide.
    Feng GK; Liu RB; Zhang MQ; Ye XX; Zhong Q; Xia YF; Li MZ; Wang J; Song EW; Zhang X; Wu ZZ; Zeng MS
    J Control Release; 2014 Oct; 192():236-42. PubMed ID: 25058570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa.
    Pemmari T; Ivanova L; May U; Lingasamy P; Tobi A; Pasternack A; Prince S; Ritvos O; Makkapati S; Teesalu T; Cairo MS; Järvinen TAH; Liao Y
    Mol Ther; 2020 Aug; 28(8):1833-1845. PubMed ID: 32497513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.
    Jaalouk DE; Ozawa MG; Sun J; Lahdenranta J; Schlingemann RO; Pasqualini R; Arap W
    Cancer Res; 2007 Oct; 67(20):9623-9. PubMed ID: 17942890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1.
    Parker MW; Linkugel AD; Vander Kooi CW
    J Mol Biol; 2013 Nov; 425(22):4405-14. PubMed ID: 23871893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and evaluation of
    Dong P; Cai H; Chen L; Li Y; Yuan C; Wu X; Shen G; Zhou H; Zhang W; Li L
    Contrast Media Mol Imaging; 2016 Nov; 11(6):467-474. PubMed ID: 27527756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for ligand and heparin binding to neuropilin B domains.
    Vander Kooi CW; Jusino MA; Perman B; Neau DB; Bellamy HD; Leahy DJ
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6152-7. PubMed ID: 17405859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
    Parker MW; Xu P; Guo HF; Vander Kooi CW
    PLoS One; 2012; 7(11):e49177. PubMed ID: 23145112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.